UC patients seem to have reduced levels of PPARγ in their colonic epithelium and similar deficiencies were observed in colitis mouse models, but only in macrophages of the lamina propria [15], [16]; confirming the beneficial effects of PPARγ agonists on the attenuation of colon inflammation [17], [18]. Here, PPARG is linked to colitis.